SHC (Sotera Health Co) Stock Based Compensation: $37 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHC Sotera Health Co SHC
76 GF Score
Price $18.79
GF Value $16.41
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Sotera Health Co Stock Based Compensation?

Sotera Health Co SHC -0.50% 76 Stock Based Compensation is $37 Mil as of Jun. 2026. GuruFocus rates SHC with a GF Score™ of 76/100 and a GF Value™ of $16.41 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Sotera Health Co's Stock Based Compensation for the three months ended in Jun. 2026 was $7 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 was $37 Mil.

Sotera Health Co Stock Based Compensation Related Terms

Sotera Health Co Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Sotera Health Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sotera Health Co Stock Based Compensation Chart

Sotera Health Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial 13.87 21.21 32.24 36.78 30.88

Sotera Health Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.12 7.95 7.57 14.39 7.22
SHC
76GF Score
Sotera Health Co SHC
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sotera Health Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $37 Mil.

What does a Stock Based Compensation of $37 Mil mean?
Sotera Health Co (SHC) has a Stock Based Compensation of $37 Mil as of Jun. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Sotera Health Co and its competitors.
Is Sotera Health Co's Stock Based Compensation too high?
Sotera Health Co's current Stock Based Compensation is $37 Mil. Overall, Sotera Health Co has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sotera Health Co's Stock Based Compensation compare to RDNT and VCYT?
Sotera Health Co's Stock Based Compensation of $37 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Diagnostics & Research company?
A good Stock Based Compensation depends on the Medical Diagnostics & Research industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Sotera Health Co and its competitors. Sotera Health Co's current Stock Based Compensation is $37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sotera Health Co stock overvalued right now?
Based on GuruFocus' analysis, Sotera Health Co (SHC) is currently considered Modestly Overvalued. The stock's GF Value™ is $16.41, compared to a current price of $18.79 — trading 14.5% above its estimated fair value. The current Stock Based Compensation is $37 Mil. Sotera Health Co's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Sotera Health Co (SHC), the current Stock Based Compensation is $37 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sotera Health Co (SHC) Overvalued in 2026?

Based on GuruFocus' analysis, Sotera Health Co stock appears to be overvalued. The current stock price of $18.79 is trading 14.5% above its estimated GF Value™ of $16.41. GuruFocus considers Sotera Health Co to be Modestly Overvalued.

Key valuation signals for SHC:

  • Stock Based Compensation: $37 Mil
  • GF Value™: $16.41 vs. price of $18.79 (14.5% above fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the SHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sotera Health Co Business Description

Address 9100 South Hills Boulevard, Suite 300, Broadview Heights, OH, USA, 44147
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
76GF Score

Get the complete analysis for SHC

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.79
Price
$16.41
GF Value